426 related articles for article (PubMed ID: 12376889)
21. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
[TBL] [Abstract][Full Text] [Related]
22. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
23. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
25. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
26. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
[TBL] [Abstract][Full Text] [Related]
27. Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
Monstad SE; Storstein A; Dørum A; Knudsen A; Lønning PE; Salvesen HB; Aarseth JH; Vedeler CA
Clin Exp Immunol; 2006 Apr; 144(1):53-8. PubMed ID: 16542365
[TBL] [Abstract][Full Text] [Related]
28. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
Tanaka M; Tanaka K; Tsuji S
Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305
[No Abstract] [Full Text] [Related]
29. [Paraneoplastic cerebellar degeneration].
Chabriat H; Chen QM; Poisson M; Delattre JY
Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
[TBL] [Abstract][Full Text] [Related]
30. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
Bradwell AR
Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
[No Abstract] [Full Text] [Related]
32. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
Nardelli E; Currò-Dossi B; Rizzuto N; Graus F
Clin Neurol Neurosurg; 1995 Feb; 97(1):89-94. PubMed ID: 7540522
[TBL] [Abstract][Full Text] [Related]
34. [A study on pathomechanisms of paraneoplastic neurological syndrome].
Tanaka K
Rinsho Shinkeigaku; 2001 Dec; 41(12):1150-2. PubMed ID: 12235823
[TBL] [Abstract][Full Text] [Related]
35. [Pathology of paraneoplastic syndromes of the central and peripheral nervous systems and muscle ].
Ferrer I
Rev Neurol; 2000 Dec 16-31; 31(12):1228-36. PubMed ID: 11211860
[TBL] [Abstract][Full Text] [Related]
36. A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers.
Landtblom AM; Lindvall B; Ledin T; Berlin G
Ther Apher Dial; 2008 Feb; 12(1):82-5. PubMed ID: 18257818
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
[TBL] [Abstract][Full Text] [Related]
38. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
Verschuuren J; Chuang L; Rosenblum MK; Lieberman F; Pryor A; Posner JB; Dalmau J
Acta Neuropathol; 1996; 91(5):519-25. PubMed ID: 8740233
[TBL] [Abstract][Full Text] [Related]
40. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
Ogita S; Llaguna OH; Feldman SM; Blum R
Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
